UNITED THERAPEUTICS Corp Quarterly Debt-to-equity in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
UNITED THERAPEUTICS Corp quarterly Debt-to-equity history and growth rate from Q2 2012 to Q3 2024.
  • UNITED THERAPEUTICS Corp Debt-to-equity for the quarter ending September 30, 2024 was 19 %, a 21% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 19 -5.03 -21% Sep 30, 2024
Q2 2024 20.6 -4.36 -17.5% Jun 30, 2024
Q1 2024 21.9 -4.22 -16.1% Mar 31, 2024
Q4 2023 22.4 -4.88 -17.9% Dec 31, 2023
Q3 2023 24 -4.42 -15.5% Sep 30, 2023
Q2 2023 24.9 -4.78 -16.1% Jun 30, 2023
Q1 2023 26.1 -4.74 -15.4% Mar 31, 2023
Q4 2022 27.3 -5.17 -15.9% Dec 31, 2022
Q3 2022 28.4 -5.39 -15.9% Sep 30, 2022
Q2 2022 29.7 -4.79 -13.9% Jun 30, 2022
Q1 2022 30.9 -4.45 -12.6% Mar 31, 2022
Q4 2021 32.5 -3.3 -9.22% Dec 31, 2021
Q3 2021 33.8 -3.05 -8.27% Sep 30, 2021
Q2 2021 34.5 -5.54 -13.8% Jun 30, 2021
Q1 2021 35.3 -8.54 -19.5% Mar 31, 2021
Q4 2020 35.8 -13.8 -27.8% Dec 31, 2020
Q3 2020 36.9 -7.41 -16.7% Sep 30, 2020
Q2 2020 40 +1.29 +3.33% Jun 30, 2020
Q1 2020 43.9 +11.6 +36% Mar 31, 2020
Q4 2019 49.5 +24.7 +99.6% Dec 31, 2019
Q3 2019 44.3 +16 +56.7% Sep 30, 2019
Q2 2019 38.8 +6.94 +21.8% Jun 30, 2019
Q1 2019 32.2 -5.43 -14.4% Mar 31, 2019
Q4 2018 24.8 -12.5 -33.4% Dec 31, 2018
Q3 2018 28.3 -6.41 -18.5% Sep 30, 2018
Q2 2018 31.8 +1.75 +5.82% Jun 30, 2018
Q1 2018 37.7 +14.5 +62.5% Mar 31, 2018
Q4 2017 37.3 +13.2 +54.7% Dec 31, 2017
Q3 2017 34.7 +7.92 +29.6% Sep 30, 2017
Q2 2017 30.1 -2.16 -6.7% Jun 30, 2017
Q1 2017 23.2 -18.4 -44.3% Mar 31, 2017
Q4 2016 24.1 -28.5 -54.2% Dec 31, 2016
Q3 2016 26.8 -30.4 -53.2% Sep 30, 2016
Q2 2016 32.2 -32.3 -50.1% Jun 30, 2016
Q1 2016 41.6 -22.3 -34.9% Mar 31, 2016
Q4 2015 52.6 -7.85 -13% Dec 31, 2015
Q3 2015 57.1 -6.52 -10.2% Sep 30, 2015
Q2 2015 64.6 +6.66 +11.5% Jun 30, 2015
Q1 2015 63.9 +9.49 +17.4% Mar 31, 2015
Q4 2014 60.5 +8.79 +17% Dec 31, 2014
Q3 2014 63.6 +15.4 +31.9% Sep 30, 2014
Q2 2014 57.9 +8.47 +17.1% Jun 30, 2014
Q1 2014 54.4 +3.81 +7.53% Mar 31, 2014
Q4 2013 51.7 -0.21 -0.41% Dec 31, 2013
Q3 2013 48.3 -6.07 -11.2% Sep 30, 2013
Q2 2013 49.4 -4.46 -8.28% Jun 30, 2013
Q1 2013 50.6 Mar 31, 2013
Q4 2012 51.9 Dec 31, 2012
Q3 2012 54.3 Sep 30, 2012
Q2 2012 53.9 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.